69 related articles for article (PubMed ID: 32096456)
21. Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.
Lan SH; Chao CM; Chang SP; Lu LC; Lai CC
Surg Infect (Larchmt); 2021 Oct; 22(8):763-770. PubMed ID: 33625294
[No Abstract] [Full Text] [Related]
22. Clinical Efficacy of Cefoperazone-Sulbactam versus Piperacillin-Tazobactam in the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.
Chen CH; Tu CY; Chen WC; Kuo LK; Wang YT; Fu PK; Ku SC; Fang WF; Chen CM; Lai CC
Infect Drug Resist; 2021; 14():2251-2258. PubMed ID: 34168466
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of Cefoperazone-sulbactam alone and Combined with Tigecycline in the Treatment of Multi-drug Resistant Acinetobacter Baumannii Pulmonary Infection.
Lv Q; Deng Y; Zhu X; Ruan J; Chen L
J Coll Physicians Surg Pak; 2020 Mar; 30(3):332-334. PubMed ID: 32169149
[TBL] [Abstract][Full Text] [Related]
24. Treatment efficacy of tigecycline in comparison to cefoperazone/ sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections.
Li Y; Xie J; Chen L; Meng T; Liu L; Hao R; Dong H; Wang X; Dong Y
Pak J Pharm Sci; 2020 Jan; 33(1):161-168. PubMed ID: 32122844
[TBL] [Abstract][Full Text] [Related]
25. Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients.
Chen Y; Xiang Q; Liu L
J Int Med Res; 2021 May; 49(5):3000605211019661. PubMed ID: 34057835
[TBL] [Abstract][Full Text] [Related]
26. Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
Huang CT; Chen CH; Chen WC; Wang YT; Lai CC; Fu PK; Kuo LK; Chen CM; Fang WF; Tu CY; Ku SC
Int J Antimicrob Agents; 2022 Jan; 59(1):106491. PubMed ID: 34871744
[TBL] [Abstract][Full Text] [Related]
27. The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
Lai CC; Chen WC; Kuo LK; Wang YT; Fu PK; Ku SC; Fang WF; Chen CM; Tu CY; Cheng WC; Chen CH
Medicine (Baltimore); 2023 Jul; 102(28):e34284. PubMed ID: 37443505
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation.
Wang X; Xiong L; Yu W; Huang C; Ji J; Ying C; Liu Z; Chen Y; Xiao Y
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830273
[TBL] [Abstract][Full Text] [Related]
29.
Xiao S; Zhuo C; Zhuo C
Comput Math Methods Med; 2021; 2021():1175379. PubMed ID: 34868336
[TBL] [Abstract][Full Text] [Related]
30. Cefoperazone/sulbactam-induced hemolytic anemia.
Sun XM; Liu LH; Wu Q; Wang HG
J Postgrad Med; 2023; 69(1):46-49. PubMed ID: 34528516
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Cefoperazone Sulbactam in Patients with
Kogilathota Jagirdhar GS; Rama K; Reddy ST; Pattnaik H; Qasba RK; Elmati PR; Kashyap R; Schito M; Gupta N
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978449
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
He X; Huang W; Wan X; Li X; Chang Q; Ding L
J Int Med Res; 2023 Mar; 51(3):3000605231162434. PubMed ID: 36967671
[TBL] [Abstract][Full Text] [Related]
33. Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in
Yang F; Zhao Q; Wang L; Wu J; Jiang L; Sheng L; Zhang L; Xue Z; Yi M
Pol J Microbiol; 2022 Jun; 71(2):251-256. PubMed ID: 35716168
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and pharmacodynamic analysis of cefoperazone/sulbactam for the treatment of pediatric sepsis by Monte Carlo simulation.
Ye L; Cheng L; Kong L; Zhao X; Xie G; He J; Liu H; Deng Y; Wu X; Wang T; Yang X
Anal Methods; 2022 Mar; 14(11):1148-1154. PubMed ID: 35225994
[TBL] [Abstract][Full Text] [Related]
35. Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.
Wang Z; Li Z; Luo S; Yang Z; Xing Y; Pu C; Dong J
J Int Med Res; 2021 Jun; 49(6):3000605211025367. PubMed ID: 34162261
[TBL] [Abstract][Full Text] [Related]
36. beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone.
Williams JD
Clin Infect Dis; 1997 Mar; 24(3):494-7. PubMed ID: 9114205
[TBL] [Abstract][Full Text] [Related]
37. Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia.
Viscardi S; Topola E; Sobieraj J; Duda-Madej A
Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786173
[TBL] [Abstract][Full Text] [Related]
38. Intra-abdominal infection after tumor surgery: tigecycline combined with β-lactam antibiotics versus tigecycline alone.
Cai X; Yan H; Zhang W; Zhao W; Zhang L; Wang X; Wu X; Hao Z; Guo J
BMC Cancer; 2023 Jul; 23(1):682. PubMed ID: 37474892
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different ratios of cefoperazone/sulbactam in patients with pyelonephritis.
Jiang W; Cai L
Pak J Med Sci; 2023; 39(1):55-59. PubMed ID: 36694775
[TBL] [Abstract][Full Text] [Related]
40. The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.
Xiong Z; Zeng D; Shen S; Han Z
Comput Math Methods Med; 2022; 2022():4525892. PubMed ID: 36017154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
